SCHEMBL13643302

SCHEMBL13643302

Clc1cc(-c2cc3ccccc3c3ccccc23)nc2c1cc(-c1ccc3ccccc3c1)c1ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.41
GPR84 Q9NQS5 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
MAPT P10636 1/20 0.38
GSTP1 P09211 1/20 0.37
ALDH1A1 P00352 2/20 0.36
CYP1A2 P05177 4/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
HPGD P15428 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
PIM1 P11309 1/20 0.35
CYP11B2 P19099 2/20 0.34
CCR1 P32246 1/20 0.34
CCR8 P51685 1/20 0.34
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34
CYP17A1 P05093 1/20 0.34
CYP19A1 P11511 1/20 0.34
DHFR P00374 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13643295 0.89 CYP1A2 (0.44) CYP11B1L3MBTL1MAPTGSTP1ALDH1A1
SCHEMBL13643280 0.87 ALDH1A1 (0.42) CYP11B1L3MBTL1MAPTALDH1A1CYP1A2
SCHEMBL13643293 0.82 GSTP1 (0.42) CYP11B1GPR84L3MBTL1MAPTGSTP1
SCHEMBL13643281 0.79 NPC1 (0.43) CYP11B1L3MBTL1MAPTALDH1A1CYP1A2
SCHEMBL28270535 0.78 GSTP1 (0.57) CYP11B1GPR84L3MBTL1MAPTGSTP1
SCHEMBL25912471 0.77 GSTP1 (0.46) CYP11B1GPR84L3MBTL1GSTP1ALDH1A1
SCHEMBL13643291 0.77 ALDH1A1 (0.43) CYP11B1L3MBTL1MAPTALDH1A1HPGD
SCHEMBL13083966 0.76 CYP11B1 (0.47) CYP11B1L3MBTL1MAPTALDH1A1CYP1A2
SCHEMBL17875449 0.76 CYP11B1 (0.50) CYP11B1GPR84L3MBTL1MAPTALDH1A1
SCHEMBL12211141 0.76 CYP1A2 (0.49) CYP11B1GPR84L3MBTL1MAPTGSTP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796917-B2 Compound for an organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode CHEIL INDUSTRIES, INC (KR) 2014-08-05 US disclosed
US-8796917-B2 Compound for an organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode CHEIL INDUSTRIES, INC (KR) 2014-08-05 US disclosed
US-20120280613-A1 COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE CHEIL INDUSTRIES, INC. (KR) 2012-11-08 US disclosed
US-20120280613-A1 COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE CHEIL INDUSTRIES, INC. (KR) 2012-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120280613-A1 COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE OR51E2, AOX1, OR10J3 CYP11B1 833/4885GPR84 1156/4885L3MBTL1 1339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.